spacer
spacer

PDBsum entry 4mds

Go to PDB code: 
protein ligands links
Hydrolase/hydrolase inhibitor PDB id
4mds

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
303 a.a.
Ligands
23H
DMS ×2
Waters ×442
PDB id:
4mds
Name: Hydrolase/hydrolase inhibitor
Title: Discovery of n-(benzo[1,2,3]triazol-1-yl)-n-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (sars- cov) 3clpro inhibitors: identification of ml300 and non-covalent nanomolar inhibitors with an induced-fit binding
Structure: 3c-like proteinase. Chain: a. Fragment: unp residues 3241-3542. Synonym: 3cl protease, 3cl-pro, 3clp, nsp5. Engineered: yes
Source: Sars coronavirus. Sars-cov. Organism_taxid: 227859. Gene: 1a. Expressed in: escherichia coli. Expression_system_taxid: 562
Resolution:
1.60Å     R-factor:   0.172     R-free:   0.212
Authors: A.D.Mesecar,V.Grum-Tokars
Key ref: M.Turlington et al. (2013). Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding. Bioorg Med Chem Lett, 23, 6172-6177. PubMed id: 24080461 DOI: 10.1016/j.bmcl.2013.08.112
Date:
23-Aug-13     Release date:   02-Oct-13    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P0C6U8  (R1A_CVHSA) -  Replicase polyprotein 1a from Severe acute respiratory syndrome coronavirus
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
4382 a.a.
303 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class 1: E.C.2.7.7.50  - mRNA guanylyltransferase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: a 5'-end diphospho-ribonucleoside in mRNA + GTP + H+ = a 5'-end (5'-triphosphoguanosine)-ribonucleoside in mRNA + diphosphate
5'-end diphospho-ribonucleoside in mRNA
+ GTP
+ H(+)
= 5'-end (5'-triphosphoguanosine)-ribonucleoside in mRNA
+ diphosphate
   Enzyme class 2: E.C.3.4.19.12  - ubiquitinyl hydrolase 1.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Thiol-dependent hydrolysis of ester, thiolester, amide, peptide and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-residue protein attached to proteins as an intracellular targeting signal).
   Enzyme class 3: E.C.3.4.22.-  - ?????
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 4: E.C.3.4.22.69  - Sars coronavirus main proteinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Added reference    
 
 
DOI no: 10.1016/j.bmcl.2013.08.112 Bioorg Med Chem Lett 23:6172-6177 (2013)
PubMed id: 24080461  
 
 
Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding.
M.Turlington, A.Chun, S.Tomar, A.Eggler, V.Grum-Tokars, J.Jacobs, J.S.Daniels, E.Dawson, A.Saldanha, P.Chase, Y.M.Baez-Santos, C.W.Lindsley, P.Hodder, A.D.Mesecar, S.R.Stauffer.
 
  ABSTRACT  
 
Herein we report the discovery and SAR of a novel series of SARS-CoV 3CLpro inhibitors identified through the NIH Molecular Libraries Probe Production Centers Network (MLPCN). In addition to ML188, ML300 represents the second probe declared for 3CLpro from this collaborative effort. The X-ray structure of SARS-CoV 3CLpro bound with a ML300 analog highlights a unique induced-fit reorganization of the S2-S4 binding pockets leading to the first sub-micromolar noncovalent 3CLpro inhibitors retaining a single amide bond.
 

 

spacer

spacer